CollabRx
CollabRx, Medytox Reach Merger Agreement
Under the terms of the deal, CollabRx will operate as a wholly owned subsidiary of the combined firm, and its shareholders will own 10 percent of the new company.Â
CollabRx, Medytox Negotiating Merger
The firms have inked a non-binding letter of intent to negotiate a merger, and Medytox has provided CollabRx with a loan.
CollabRx, Cartagenia Partner to Provide Comprehensive Solution for Cancer Testing
NEW YORK (GenomeWeb) – CollabRx and Cartagenia have teamed up to provide an end-to-end software solution for clinical laboratories that supports genetic testing and reporting, including next-generation sequencing-based tests, in oncology.
The TranSmart Foundation has launched version 1.2 of its open-source knowledge management platform for life science research.
NEW YORK (GenomeWeb) – CollabRx said this week that Singapore-based private oncology firm OncoSolutions Cancer Center has signed a multi-year agreement to use CollabRx's Genetic Variant Annotation (GVA) service to analyze tumor genetic data.
Jul 16, 2012
Tegal Completes Purchase of CollabRx
Jul 3, 2012
Jul 2, 2012
Tegal Buys CollabRx
Nov 9, 2011